MYNX CONTROL Vascular Closure Device

The outstanding design and predictable deployment of MYNX CONTROL Vascular Closure Device delivers outstanding performance and control, for reliable secure arterial closures.*

Product Description

MYNX CONTROL Vascular Closure Device integrates active extravascular sealing and resorbability properties with a next-generation delivery system to maximize predictability, safety, and ease of use in sealing 5-7F femoral arterial access sites.

Featuring:

MYNX™ VCD has been clinically proven to reduce surgical complications, expedite recovery, shorten hospital stays, and increase patient comfort (1-5).

1Pruski MJ Jr et al. MynxGrip for closure of antegrade puncture after peripheral interventions with same-day discharge. Vasc Endovasc Surg. 2017 Feb;51(2):67-71.
2Baker NC et al. Active versus passive anchoring vascular closure devices following percutaneous coronary intervention: a safety and efficacy comparative analysis. J Interv Cardiol. 2016 Feb; 29(1): 108-112.
3Hutchings D et al. Success, safety, and efficacy of the Mynx femoral closure device in a real-world cohort: single-center experience. J Invasive Cardiol. 2016 Mar;28(3):104-108.
4 Noor S et al. Successful reduction of surgeries secondary to arterial access site complications: a retrospective review at a single center with an extravascular closure device. Vasc Endovascular Surg. 2010 Jul;44(5):345-349.
5 Fargen KM et al. A prospective randomized single-blind trial of patient comfort following vessel closure: extravascular synthetic sealant closure provides less pain than a self-tightening suture

The MYNX CONTROL™ VCD includes:

  • (1) MYNX CONTROL™ VCD including balloon catheter and integrated polyethylene glycol sealant
  • (1) 10 ml locking syringe
ProductSizeOrder Number

MYNX CONTROL™ VCD

5FMX5060E
MYNX CONTROL™ VCD6F / 7FMX6760E
Scroll to Top